|The BRCA2 brca2 (Catalog #MBS829691) is a Blocking Peptide produced from Synthetic and is intended for research purposes only. The product is available for immediate purchase. The BRCA2 Blocking Peptide reacts with Human, Rat, Monkey and may cross-react with other species as described in the data sheet. MyBioSource\'s BRCA2 can be used in a range of immunoassay formats including, but not limited to, Blocking (BL). Researchers should empirically determine the suitability of the BRCA2 brca2 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The BRCA2 brca2 product has the following accession number(s) (GI #119395734) (NCBI Accession #NP_000050.2) (Uniprot Accession #P51587). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
The peptide is used to block Anti-BRCA2 Antibody reactivity.
Quality Control: The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry.
Directions for Use: Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 degree C for overnight or at room temperature for 2 hours. BRCA2 also interacts with the following gene(s): ATM, BRCA1, CDK2, FANCD2, FANCG, PALB2, RAD51, RAD51C, SHFM1, XRCC3. The following patways have been known to be associated with this gene. Bone Marrow, Brain, Embryonic Tissue, Kidney, Liver, Lung, Lymph Node, Mammary Gland, Pancreas, Vascular tissues are correlated with this protein. Adenocarcinoma, Anemia, Breast Neoplasms, Fanconi Anemia, Hereditary Breast and Ovarian Cancer Syndrome, Neoplasm Metastasis, Neoplasms, Experimental, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms are some of the diseases may be linked to BRCA2 Blocking Peptide.